Disclosure Panels Details Page
Neuroendocrine Tumors Panel - Disclosures as of 08/22/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Al Benson III MD, FACCC, FACP, FASCO | None | Astellas Pharma US, Inc. Bayer HealthCare Bristol Myers Squibb Eli Lilly and Company Exelixis Inc. Genentech, Inc. Merck & Co., Inc. Purdue Pharma LP |
None | None | ✔ |
| Emily Bergsland MD | Lexicon Pharmaceuticals, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation |
MOREHealth | None | None | - |
| Jordan Berlin MD | AstraZeneca Pharmaceuticals LP Celgene Corporation |
armo AstraZeneca Pharmaceuticals LP BeiGene Celgene Corporation EMD serono Erytech Fiveprime gritstone karyopharm rafael symphogen |
None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Lawrence Blaszkowsky MD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Jennifer Chan MD | Eli Lilly and Company Exelixis Inc. sanofi-aventis U.S. |
Advanced Accelerator Applications Ipsen Novartis Pharmaceuticals Corporation |
None | Merck & Co., Inc. | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | - |
| Mary Dwyer MS | None | None | None | None | - |
| Paul Engstrom MD, FACP | None | None | None | None | ✔ |
| Paul Fanta MD | None | None | None | None | - |
| Thomas Giordano MD, PhD | None | Rosetta Genomics | None | None | - |
| Whitney Goldner MD | Eisai Inc. Roche Laboratories, Inc. |
None | None | None | ✔ |
| John Grecula MD | Teva Pharmaceutical Industries Ltd | NOXXON Pharma 2017 | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Thorvardur Halfdanarson MD | Ipsen Thermo Fisher |
Ipsen Lexicon Pharmaceuticals, Inc |
None | None | - |
| Daniel Halperin MD | Genentech, Inc. Ipsen Novartis Pharmaceuticals Corporation Tarveda |
AbbVie, Inc. Ipsen Lexicon Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jin He MD, PhD | None | None | None | None | ✔ |
| Martin Heslin MD | None | BestDoctors | None | None | ✔ |
| Gregory Kalemkerian MD | AbbVie, Inc. GSK Merck & Co., Inc. Takeda Pharmaceuticals North America, Inc. |
None | None | None | - |
| Fouad Kandeel MD, PhD | None | None | None | None | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Sajid Khan MD | None | None | None | None | ✔ |
| Pamela Kunz MD | None | Ipsen Lexicon |
None | None | ✔ |
| Boris Kuvshinoff MD, MBA | None | None | None | None | ✔ |
| Christopher Lieu MD | None | None | None | None | - |
| Robert Merritt MD | None | None | None | None | ✔ |
| Gareth Morris-Stiff MD, PhD, MBBCh, FACS, FRCS | None | None | AbbVie, Inc. | None | ✔ |
| Venu Pillarisetty MD | Ipsen Merck & Co., Inc. |
Merck & Co., Inc. | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Leonard Saltz MD | Taiho Pharmaceuticals Co., Ltd. | None | None | None | ✔ |
| Manisha Shah MD | Eisai Inc. LOXO oncology Merck & Co., Inc. |
Eisai Inc. Ignyta Loxo Novartis Pharmaceuticals Corporation |
None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Jonathan Strosberg MD | None | Novartis Pharmaceuticals Corporation | Ipsen Lexicon |
None | ✔ |
| Craig Sussman MD | None | None | None | None | ✔ |
| Nikolaos Trikalinos MD | None | None | None | None | ✔ |
| Nataliya Uboha MD, PhD | None | EMD Serono Flatiron Health, Inc. |
None | None | - |
| Jonathan Whisenant MD | None | None | None | None | ✔ |
| Terence Wong MD, PhD, FACR | None | None | None | None | ✔ |
| Griselda Zuccarino-Catania PhD | None | None | None | Janssen Pharmaceutica Products, LP | - |